Distinct mitral valve proteomic profiles in rheumatic heart disease and Myxomatous degeneration

Clinical Medicine Insights: Cardiology

Volumn 8, Issue , 2014, Pages 79-86

  Martins, Carlo de Oliveira ^a   Santos, Keity Souza ^a   Ferreira, Frederico Moraes ^a   Teixeira, Priscila Camillo ^a,b   Pomerantzeff, Pablo Maria Alberto ^a   Brandão, Carlos M A ^a   Sampaio, Roney Orismar ^a   Spina, Guilherme S ^a   Kalil, Jorge ^a   Guilherme, Luiza ^a   Cunha Neto, Edecio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

2DE DIGE; Heart valve proteins; IPA; Myxomatous degeneration; Rheumatic heart disease

Indexed keywords

APOLIPOPROTEIN A1; BIGLYCAN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 6; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOPLASM PROTEIN; DEVELOPMENT AND DIFFERENTIATION ENHANCING FACTOR 2; HAPTOGLOBIN RELATED PROTEIN; LIPOCORTIN 1; LIPOCORTIN 2; LUMICAN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 25; MEMBRANE PROTEIN; PROLARGIN; SCLEROPROTEIN; SEPTIN 2; TRANSFORMING GROWTH FACTOR BETA; TRANSGELIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; ISOELECTRIC FOCUSING; MALE; MASS SPECTROMETRY; MIDDLE AGED; MITRAL VALVE DISEASE; MITRAL VALVE REPLACEMENT; MYXOMATOUS DEGENERATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RHEUMATIC HEART DISEASE; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 84907327505     PISSN: None     EISSN: 11795468     Source Type: Journal    
DOI: 10.4137/CMC.S17622     Document Type: Article

References (37)

1. Ekelund K, Skinhøj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect. 2005; 11(7): 569-76.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005; 5(11): 685-94.
3. Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Rev Physiol. 2011; 73: 29-46.
4. Guilherme L, Köhler KF, Postol E, Kalil J. Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Cardiol. 2011; 4(1): 13-21.
5. Guilherme L, Köhler KF, Kalil J. Rheumatic heart disease: mediation by complex immune events. Adv Clin Chem. 2011; 53: 31-50.
6. Tandon R, Sharma M, Chandrashekhar Y, Kotb M, Yacoub MH, Narula J. Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol. 2013.
7. He Y, Guo Y, Li Z, et al. Echocardiographic determination of the prevalence of primary myxomatous degeneration of the cardiac valves. J Am Soc Echocardiogr. 2011; 24(4): 399-404.
8. Pellerin D, Brecker S, Veyrat C. Degenerative mitral valve disease with emphasis on mitral valve prolapse. Heart. 2002; 88(suppl 4): iv20-8.
9. Caira FC, Stock SR, Gleason TG, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol. 2006; 47(8): 1707-12.
10. Akhtar S, Meek KM, James V. Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae. Cardiovasc Pathol. 1999; 8(4): 191-201.
11. Mahimkar R, Nguyen A, Mann M, et al. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. Cardiovasc Pathol. 2009; 18(5): 253-61.
12. Yin Z, Jones GN, Towns WH2nd, et al. Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. Circulation. 2008; 117(11): 1414-22.
13. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999; 20(18): 3551-67.
14. Shoeman RL, Hartig R, Traub P. Characterization of the nucleic acid binding region of the intermediate filament protein vimentin by fluorescence polarization. Biochemistry. 1999; 38(51): 16802-09.
15. Challa AA, Stefanovic B. A novel role of vimentin filaments: binding and stabilization of collagen mRNAs. Mol Cell Biol. 2011; 31(18): 3773-89.
16. Faé KC, Diefenbach daSilvaD, Bilate AM, et al. PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J Autoimmun. 2008; 31(2): 136-41.
17. Kwak HI, Kang H, Dave JM, et al. Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation. Angiogenesis. 2012; 15(2): 287-303.
18. El-Demellawy M, El-Ridi R, Guirguis NI, Abdel Alim M, Kotby A, Kotb M. Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients. Infect Immun. 1997; 65(6): 2197-205.
19. Dinkla K, Nitsche-Schmitz DP, Barroso V, et al. Identification of a streptococcal octapeptide motif involved in acute rheumatic fever. J Biol Chem. 2007; 282(26): 18686-93.
20. Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem. 1997; 272(42): 26522-9.
21. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 1998; 17(1): 1-19.
22. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol. 1997; 32(2): 141-74.
23. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998; 141(5): 1277-86.
24. Grover J, Chen XN, Korenberg JR, Roughley PJ. The human lumican gene. Organization, chromosomal location, and expression in articular cartilage. J Biol Chem. 1995; 270(37): 21942-9.
25. Dolhnikoff M, Morin J, Roughley PJ, Ludwig MS. Expression of lumican in human lungs. Am J Respir Cell Mol Biol. 1998; 19(4): 582-7.
26. Funderburgh JL, Funderburgh ML, Mann MM, Conrad GW. Arterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J Biol Chem. 1991; 266(36): 24773-7.
27. Vuillermoz B, Khoruzhenko A, D'Onofrio MF, et al. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res. 2004; 296(2): 294-306.
28. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000; 13(3): 470-511.
29. Guilherme L, Faé K, Oshiro SE, Kalil J. Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med. 2005; 7(28): 1-15.
30. Reilly JT, Nash JR. Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue. J Clin Pathol. 1988; 41(12): 1269-72.
31. Seiffert D. Constitutive and regulated expression of vitronectin. Histol Histopathol. 1997; 12(3): 787-97.
32. Preissner KT. Structure and biological role of vitronectin. Annu Rev Cell Biol. 1991; 7: 275-310.
33. Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol. 2004; 165(5): 1583-91.
34. Kojima S, Itoh Y, Matsumoto S, Masuho Y, Seiki M. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett. 2000; 480(2-3): 142-6.
35. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001; 104(21): 2525-32.
36. Kim L, Kim doK, Yang WI, et al. Overexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease. J Korean Med Sci. 2008; 23(1): 41-8.
37. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007; 171(5): 1407-18.